TY  - JOUR
AU  - Alsina, Maria
AU  - Rivera, Fernando
AU  - Ramos, Francisco Javier
AU  - Galan, Maica
AU  - Lopez, Rafael
AU  - Garcia-Alfonso, Pilar
AU  - Ales-Martinez, Jose Enrique
AU  - Queralt, Bernardo
AU  - Anton, Antonio
AU  - Carrato, Alfredo
AU  - Gravalos, Cristina
AU  - Mendez-Vidal, Maria Jose
AU  - Lopez, Carlos
AU  - de Mena, Inmaculada Ruiz
AU  - Tabernero, Josep
AU  - Giralt, Jordi
AU  - Aranda, Enrique
PY  - 2018
DO  - 10.1007/s11523-017-0536-z
UR  - http://hdl.handle.net/10668/11911
T2  - Targeted oncology
AB  - Background: Pre-operative chemoradiotherapy using a 5-fluorouracil (5-FU)/cisplatin backbone is widely used to improve surgical outcomes in locoregional oesophageal cancer patients, despite a non-negligible failure rate. Objective: We evaluated...
LA  - en
PB  - Springer
KW  - Adult
KW  - Aged
KW  - Cetuximab / pharmacology
KW  - Cetuximab / therapeutic use*
KW  - Chemoradiotherapy / methods*
KW  - Esophageal neoplasms
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle aged
TI  - A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
TY  - research article
VL  - 13
ER  -